When patients with HIV infection also are addicted to opioids, treating both disorders simultaneously may help improve outcomes and reduce the spread of HIV or other infections transmitted through needle sharing or risky sexual behaviors associated with injection drug use. But accessing such integrated care has sometimes been a challenge for such patients, who generally had to seek care for opioid abuse at addiction treatment centers and primary HIV care elsewhere. This could be logistically difficult and often led to delays in receiving care.
Kuehn BM. Buprenorphine May Boost HIV Treatment. JAMA. 2010;304(3):261–263. doi:10.1001/jama.2010.963
Customize your JAMA Network experience by selecting one or more topics from the list below.